1. Clinical Overview
Ambroxol is a potent mucolytic and expectorant agent, a metabolite of bromhexine. It is a benzylamine derivative that works by increasing the production of pulmonary surfactant and stimulating the serous component of bronchial secretions. It is widely used in the management of acute and chronic respiratory diseases associated with viscid mucus, particularly in the Indian context where air pollution and seasonal changes exacerbate respiratory conditions.
| Onset | Duration | Bioavailability |
|---|---|---|
| Approximately 30 minutes after oral administration. | Approximately 6 to 12 hours. | Approximately 70-80% after oral administration. |
2. Mechanism of Action
Ambroxol exerts its mucolytic action through multiple mechanisms: 1) It stimulates the synthesis and secretion of surfactant from type II alveolar pneumocytes. Surfactant reduces the adhesion of mucus to the bronchial wall. 2) It depolymerizes and lyses acid mucopolysaccharide fibers in sputum, reducing its viscosity and elasticity. 3) It activates the hydrolytic enzymes of the serous cells in the bronchial glands (e.g., sialidase), leading to a more fluid, serous secretion. 4) It enhances ciliary beat frequency and mucociliary transport, facilitating expectoration.
3. Indications & Uses
- Acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport (e.g., Acute Bronchitis, Chronic Bronchitis).
- Bronchiectasis.
- Tracheobronchitis.
- Asthma with difficult expectoration.
4. Dosage & Administration
Adult Dosage: 30mg (5ml) two to three times daily. Maximum daily dose: 90-120mg.
Administration: Should be taken after meals with a full glass of water to minimize gastric irritation and to aid in systemic hydration, which supports mucolytic action. Use the measuring cup or spoon provided. Do not use a household spoon.
5. Side Effects
Common side effects may include:
- Gastrointestinal: Nausea, vomiting, dyspepsia, diarrhea, abdominal pain.
- Mild allergic reactions: Skin rash, urticaria.
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Antitussives (e.g., Codeine, Dextromethorphan) | Concomitant use may counteract the expectorant effect of ambroxol by suppressing the cough reflex, leading to accumulation of liquefied secretions. | Moderate |
| Antibiotics (e.g., Amoxicillin, Cefuroxime, Erythromycin) | Ambroxol may increase the penetration of certain antibiotics into bronchial secretions, potentially enhancing their efficacy in lung infections. | Minor (Beneficial) |
| ACE Inhibitors (e.g., Enalapril, Lisinopril) | Increased risk of cough (a class effect of ACE inhibitors) which may be confused with the underlying condition. | Minor |
7. Patient Counselling
- DO take the medication after meals with a full glass of water.
- DO maintain adequate fluid intake (2-3 liters per day unless contraindicated) to help loosen mucus.
- DO use the measuring device provided with the syrup.
- DO inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- DONT take cough suppressants (antitussives) with ambroxol unless specifically advised by your doctor.
- DONT use in children under 2 years without consulting a doctor.
- DONT exceed the recommended dose.
8. Toxicology & Storage
Overdose: Symptoms are an extension of side effects: Severe nausea, vomiting, diarrhea, abdominal pain, hypotension, dizziness, and agitation. No specific organ toxicity is reported at typical overdose levels.
Storage: Store at room temperature (15-25°C), protected from light and moisture. Keep the bottle tightly closed. Keep out of reach of children. Do not freeze. Discard any unused medicine after the expiry date.